Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Determine the Effect of AMG 785 on Fracture Healing
2009-015939-33Phase 2Completed
- Sponsor
- Amgen
- Start
- Jan 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in fracture healing comparing AMG 785 with Placebo (2 arms). Primary endpoint: Timed-Up-and-Go (TUG) performance over weeks 6–20. Started Jan 2010; status: completed.
02
Drugs
romosozumab
03
Conditions
fracture healing
Beyond the preview
Go deeper on 2009-015939-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015939-33.